1988
DOI: 10.1016/0741-8329(88)90025-0
|View full text |Cite
|
Sign up to set email alerts
|

Blood cell superoxide dismutase and enolase activities as markers of alcoholic and nonalcoholic liver diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1991
1991
2013
2013

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…Ohman and Marklund (1986) found no variation in SOD activity in such patients. Conversely, Ledig et al (1988) observed an increase in SOD in alcoholics with liver disease (steatosis, cirrhosis with or without ascites); this evaluation appeared associated with the degree of liver injury. Such an increase was also reported by Emerit et al (1984) in a restricted population of alcoholics with severe liver injury.…”
Section: Discussionmentioning
confidence: 67%
“…Ohman and Marklund (1986) found no variation in SOD activity in such patients. Conversely, Ledig et al (1988) observed an increase in SOD in alcoholics with liver disease (steatosis, cirrhosis with or without ascites); this evaluation appeared associated with the degree of liver injury. Such an increase was also reported by Emerit et al (1984) in a restricted population of alcoholics with severe liver injury.…”
Section: Discussionmentioning
confidence: 67%
“…Data on superoxide dismutase activity, an antioxidant defence enzyme that reduces superoxide to hydrogen peroxide, 21 in the blood of alcoholics are contradictory: increased 8 , 22 , 23 and decreased 23 , 24 activity have been reported. In the present study, differences between the superoxide dismutase activities of alcoholic patients, who continuously consumed excess alcohol, patients with end‐stage non‐alcoholic liver disease and healthy controls were small (Table 2) and probably not important.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, there is a need for simple non-invasive and definitive markers of early changes in the development of ALD. Several have been proposed including serum beta-hexosaminidase [5,6], increased activity of superoxide dismutase (SOD) and neuron-specific enolase (NSE) in blood cells [7], increased levels of lymphocyte cytochrome P450 CYP2E1 [8]. A metabolomics study in mice revealed two metabolites in urine, N -acetylglutamine and N -acetylglycine, that might be useful markers for ALD [9].…”
Section: Introductionmentioning
confidence: 99%